Press Releases

Press Releases

August 2, 2018

IRVINE, Calif. , Aug. 02, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today reported financial results for the second quarter ended June 30, 2018. Second Quarter 2018 and Recent Highlights: Announced early resubmission to the U.S.

July 18, 2018

IRVINE, Calif. , July 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today the pricing of its public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per share, before underwriting discounts and commissions.  The offering consists of

July 16, 2018

IRVINE, Calif. , July 16, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) and commenced a proposed underwritten public offering of 5,000,000 shares of its

June 14, 2018

IRVINE, Calif. , June 14, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (“Evolus”) (NASDAQ:EOLS), a premiere aesthetics company, announced today that members of management will be participating in two upcoming investor conferences in New York, NY .                   Event:   Cantor 2018 Dermatology &

Displaying 11 - 20 of 35